# The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study

> **NCT05655689** · — · COMPLETED · sponsor: **Alexandria University** · enrollment: 123 (actual)

## Conditions studied

- Bacterial Keratitis
- Fungal Keratitis
- Mixed Bacterial and Fungal Keratitis
- Microbial Keratitis

## Interventions

- **DRUG:** Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
- **DRUG:** Ceftazidime 5% + vancomycin 5%
- **DRUG:** Gentamicin 1.4% + vancomycin 5%
- **DRUG:** Natamycin 5% Oph Susp
- **DRUG:** Voriconazole 1%
- **DRUG:** Natamycin 5% + voriconazole 1%
- **DRUG:** Natamycin 5%+ ceftazidime 5% + vancomycin 5%
- **DRUG:** Voriconazole 1% + ceftazidime 5% + vancomycin 5%

## Key facts

- **NCT ID:** NCT05655689
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-31
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2024-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05655689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05655689, "The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05655689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*